Feinberg M B
Office of AIDS Research, National Institutes of Health, Bethesda, MD 20892, USA.
Lancet. 1996 Jul 27;348(9022):239-46. doi: 10.1016/s0140-6736(96)06231-9.
Our understanding of the pathogenesis of AIDS has advanced considerably since the disease was first reported 15 years ago. We now know that the primary damage inflicted by HIV-1 is mainly brought about by active virus replication. With the advent of sensitive tools for monitoring HIV replication in vivo, an individual's risk of disease progression can be assessed early in the course of the infection and the efficacy of antiviral therapies can now be determined accurately and expeditiously. When used appropriately, potent combinations of antiviral drugs seem to be able to circumvent the inherent tendency of HIV-1 to generate drug-resistant viruses, the main reason for failure of all antiviral therapies, and are significantly more effective than earlier approaches. For the first time, rational approaches to contain and perhaps eliminate HIV-1 infection can be pursued.
自15年前首次报告艾滋病以来,我们对艾滋病发病机制的理解有了很大进展。我们现在知道,HIV-1造成的主要损害主要是由活跃的病毒复制引起的。随着用于监测体内HIV复制的敏感工具的出现,个体疾病进展的风险可以在感染过程的早期进行评估,并且现在可以准确、迅速地确定抗病毒治疗的疗效。如果使用得当,强效抗病毒药物组合似乎能够规避HIV-1产生耐药病毒的内在倾向,而这是所有抗病毒治疗失败的主要原因,并且比早期方法显著更有效。首次可以采用合理的方法来控制甚至消除HIV-1感染。